Keyword: Fresenius Kabi

Strategy & Management

Along the Acquisition Trail

17.04.2018 - For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...

News

Death Penalty Drugs Under Scrutiny Again

21.04.2017 - As a debate rages over plans by the US state of Arkansas to execute eight death row inmates before its supply of lethal drugs expires at the end of April, the international...

Plant Construction & Process Technology

Highly Potent API Demand is On the Rise

24.10.2013 - Small But Mighty - Highly potent active ingredients (HPAPIs) are remarkably effective at small doses. Therapies including oncology, hormones, narcotics, musculoskeletal treatments...

News

Fresenius Kabi Blocked Shipments to U.S. Distributor After Drug Sent For Executions

11.10.2013 - A German manufacturer confirmed on Thursday that it took the extraordinary step of suspending shipments of a widely used drug to a U.S. distributor this year after 20 vials were...

News

Fresenius Buys Fenwal for $1.1 Billion

21.07.2012 - Fresenius brushed aside difficulties acquiring Rhoen-Klinikum, instead agreeing on Friday to buy blood collection equipment specialist Fenwal Holdings in a deal sources valued at...

News

Small Generic Drug Firms Need Niches to Survive Looming Price War

21.07.2012 - Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...

News

Fresenius Lifts Outlook again on Rivals' Shortages

11.06.2012 - German healthcare conglomerate Fresenius on Monday raised its 2012 profit outlook for a second time this year as its injectable generic drugs unit Kabi continues to benefit from...